Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Core Scientific (CORZ) Shares Outstanding (Diluted Average) (2020 - 2026)

Core Scientific has reported Shares Outstanding (Diluted Average) over the past 7 years, most recently at $322.9 million for Q1 2026.

  • Quarterly results put Shares Outstanding (Diluted Average) at $322.9 million for Q1 2026, down 11.12% from a year ago — trailing twelve months through Mar 2026 was $322.9 million (down 11.12% YoY), and the annual figure for FY2025 was $318.1 million, up 24.33%.
  • Shares Outstanding (Diluted Average) reached $322.9 million in Q1 2026 per CORZ's latest filing, up from $318.1 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $382.5 million in Q3 2023 and bottomed at $207.1 million in Q2 2024.
  • Median Shares Outstanding (Diluted Average) over the past 5 years was $322.9 million (2026), compared with a mean of $322.3 million.
  • The largest annual shift saw Shares Outstanding (Diluted Average) soared 83.24% in 2022 before it tumbled 44.9% in 2024.
  • Over 5 years, Shares Outstanding (Diluted Average) stood at $340.6 million in 2022, then increased by 11.51% to $379.9 million in 2023, then plummeted by 32.65% to $255.8 million in 2024, then grew by 24.33% to $318.1 million in 2025, then grew by 1.52% to $322.9 million in 2026.
  • Business Quant data shows Shares Outstanding (Diluted Average) for CORZ at $322.9 million in Q1 2026, $318.1 million in Q4 2025, and $317.4 million in Q3 2025.